Clinical Trial Update: Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing oral valsartan/amlodipine combination therapy to amlodipine monotherapy in stage II hypertension. The update reports on efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED